Literature DB >> 3773096

The value of computerized tomography scan and magnetic resonance imaging in staging prostatic carcinoma: comparison with the clinical and histological staging.

E Mukamel, J Hannah, Z Barbaric, J B deKernion.   

Abstract

In 21 patients adenocarcinoma of the prostate was staged preoperatively by digital rectal examination, computerized tomography and magnetic resonance imaging. Clinical staging was compared to the postoperative pathological staging. In 11 patients computerized tomography, magnetic resonance imaging and digital rectal examination findings were concordant with the histological examination showing tumors confined to the prostate. In 10 patients no correlation between preoperative staging and histology was noted. Of these cases 8 were understaged by computerized tomography, magnetic resonance imaging and digital rectal examination. In 1 patient magnetic resonance imaging showed false positive findings and in another staging with computerized tomography and magnetic resonance imaging was more accurate than digital rectal examination. Our experience indicates that computerized tomography and magnetic resonance imaging have limited value in the preoperative staging of prostatic carcinoma. Moreover, staging with computerized tomography and magnetic resonance imaging does not significantly improve the information gained by digital rectal examination.

Entities:  

Mesh:

Year:  1986        PMID: 3773096     DOI: 10.1016/s0022-5347(17)45294-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Cost-analysis of staging methods for lymph nodes in patients with prostate cancer: MRI with a lymph node-specific contrast agent compared to pelvic lymph node dissection or CT.

Authors:  Anke M Hövels; Roel A M Heesakkers; Eddy M Adang; Gerrit J Jager; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2004-07-13       Impact factor: 5.315

2.  The effectiveness of imaging modalities in clinical staging of localized prostatic carcinoma.

Authors:  T Tarcan; L Türkeri; T Biren; S Küllü; N Gürmen; A Akdaş
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

3.  The importance of pelvic lymph node dissection in men with clinically localized prostate cancer.

Authors:  Mohamad E Allaf; Alan W Partin; H Ballentine Carter
Journal:  Rev Urol       Date:  2006

4.  Clinical experience with intra lymphatic administration of 111In-labelled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma.

Authors:  H H Abdel-Nabi; J A Ortman-Nabi; W See; J Lee; R Ireton; M Boileau; M W Unger; C Halverson
Journal:  Eur J Nucl Med       Date:  1990

5.  Prostate cancer topography and patterns of lymph node metastasis.

Authors:  Yuji Tokuda; Lauren J Carlino; Anuradha Gopalan; Satish K Tickoo; Matthew G Kaag; Bertrand Guillonneau; James A Eastham; Howard I Scher; Peter T Scardino; Victor E Reuter; Samson W Fine
Journal:  Am J Surg Pathol       Date:  2010-12       Impact factor: 6.394

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.